The recent steep increase in cases of acute hepatitis C virus infection, associated with increases in opioid injection, could have devastating long-term consequences.
In our final installment of 2017, we intermingle forward-looking research with some retrospective analysis. We begin our four-study tour by joining researchers in Tennessee for an exercise in HIV outbreak prediction.
HIV.gov shares their conversations with several presenters and participants at USCA 2017 about HIV-related stigma and curing hepatitis C coinfection among people living with HIV.
With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic have a better chance at a cure.
Endocarditis and other invasive bacterial infections are not nearly as feared as HIV and HCV, despite the fact that the former are far more immediately life threatening and way more difficult to treat.
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
Among the updates are the addition of hepatitis C drugs and rewritten recommendations for various types of coccidioidomycosis.
At Last: Gay Men and Transgender People Get Vaccine to Prevent Genital Warts and Anal Cancer -- Impressive Pilot Results in England
Gay men and transgender people in England now have limited access to the HPV vaccine.
Hepatitis C Infection and People Who Inject Drugs is a new resource for medical providers aimed at improving the health of people who inject drugs.
South Africa has launched the world's largest national screening program to detect cryptococcal meningitis -- an AIDS-defining infection -- sooner than it would have been picked up in the past.
Hepatitis C regimens containing ledipasvir/sofosbuvir (Harvoni) or paritaprevir/ritonavir/ombitasvir and dasabuvir (Viekira Pak) cured almost 17,500 patients in the Veterans Affairs (VA) health care system.